News
National Academies issue guidance for childhood COVID-19 vaccines
Even though the COVID-19 vaccine has not yet been authorized for young children, local, state, and national leaders can begin now in getting the...
News
Pregnant women no longer detained by ICE
In a new policy issued by the Biden administration, pregnant, nursing, or postpartum undocumented immigrants will no longer be detained by ICE.
News
PPE protected critical care staff from COVID-19 transmission
Staff acquisition peaked 3 weeks before the peak of COVID-19 ICU admission.
News
First drug for MET+ NSCLC shows high response rates
Among patients with a MET exon 14 skipping mutation, capmatinib produced a response in 41% of previously treated patients and 68% of treatment-...
News
Cancer patients report delays in treatment because of COVID-19
Half of survey respondents in active treatment reported changes, delays, or disruptions to care.
News
Treating rectal cancer in the COVID-19 era: Expert guidance
Experts recommend total mesorectal excision for early- and intermediate-stage disease and a short course of preoperative radiotherapy for locally...
News
Stereotactic radiotherapy highly effective for brain mets in RCC
Stereotactic radiotherapy is highly effective for controlling brain metastases in patients with renal cell carcinoma, even in those with more than...
News
Line complications plague dose-adjusted EPOCH-R in non-Hodgkin lymphoma
The risk of line-associated complications was significantly higher with dose-adjusted EPOCH-R therapy, compared with R-CHOP, in patients with...
News
TKIs and immunotherapy hold promise for alveolar soft part sarcoma
Tyrosine kinase inhibitors and immune checkpoint inhibitors show encouraging results in the treatment of alveolar soft part sarcoma
News
Aspirin cuts risk of liver and ovarian cancer
Regular aspirin use decreased the risk of both ovarian cancer and hepatocellular carcinoma.
News
Aspirin cuts risk of ovarian and liver cancer
Regular aspirin use decreased the risk of both ovarian cancer and hepatocellular carcinoma.
News
Epacadostat plus pembrolizumab shows promise in advanced solid tumors
Investigational drug epacadostat plus pembrolizumab demonstrated promising antitumor activity and safety in patients with advanced solid tumors....